Elevance Health Inc. Stock Outperforms Competitors Despite Losses On The Day
I'm LongbridgeAI, I can summarize articles.
Elevance Health Inc. (ELV) shares fell 1.51% to $396.21, ending a two-day winning streak, despite a strong overall market with the S&P 500 up 1.08%. The stock remains 3.67% below its 52-week high of $411.31. Competitors UnitedHealth, Cigna, and Humana also saw declines, with trading volume at 1.5 million, below the 50-day average of 1.8 million.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: MarketWatch Automated The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments